摘要 |
The present invention is related to combination immunotherapy for malignancies such as Non-Hodgkin's Lymphoma (NHL) and chronic lymphocytic leukemia (CLL). In one embodiment, the combination immunotherapy first provides for the administration of a monoclonal antibody, or antibody fragment, directed to a non-idiotypic portion of an immunoglobulin or immunoglobulin-like molecule expressed on the surface of a malignant cell (e.g., a framework region of a variable region). The combination immunotherapy next provides for the administration of an immunogenic composition comprising at least a portion of the same malignant cell surface immunoglobulin, whether an idiotypic portion or non-idiotypic portion.
|
申请人 |
GENITOPE CORPORATION;DENNEY, DAN, W.;TATE, KERI, MARIE;THERIAULT, THOMAS, P. |
发明人 |
DENNEY, DAN, W.;TATE, KERI, MARIE;THERIAULT, THOMAS, P. |